The ADRB2 gene encodes the b2-adrenergic receptor (b2-AR). This study aimed to determine the association between the C79G polymorphism of the ADRB2 gene and its association with pediatric asthma using a metaanalysis of the published data.
Background
Asthma is a common chronic allergic disease that involves the respiratory tract and affects millions of children worldwide, occurring in up to 10% of children, which makes atopic asthma a global public health problem [1, 2] . Asthma is a heterogeneous disease that typically includes chronic inflammation of the airway with symptoms that include cough, shortness of breath, wheeze, chest tightness, and variably reduced expiratory airflow [3] . Several risk factors are now known to exacerbate episodes of asthma and include air pollution, exposure to environmental chemicals, microbes, and allergens, and also exposure to dander from animal fur in children who keep pets [4] [5] [6] . Recently published studies have shown that the development of asthma in children depends on genetic predisposition, and have highlighted the role of the IL17A gene that encodes interleukin 17 (IL-17), the ORMDL3 gene that encodes orosomucoid 1-like 3, and the ADRB2 gene that encodes the b2-adrenergic receptor (b2-AR).
The ADRB2 gene is a 1200 bp intron-less gene that encodes a 413 amino acid protein, b2-AR, with a molecular mass of approximately 46.5 kD [7, 8] . The b2-adrenergic receptor (b2-AR) is a prototypical G protein-coupled receptor (GPCR) with seven transmembrane domains, an extracellular amino terminus, an intracellular carboxyl terminus, three interconnecting extracellular loops, and three intracellular loops [7, 9, 10] . Because b2-AR is highly expressed in the lung tissue, mainly in the airway smooth muscles, b2-AR agonists are used as first-line bronchodilator therapy in patients with asthma [11, 12] . The gene that encodes this receptor, ADRB2, is found on the long arm of chromosome 5q31-33, and studies have shown that ADRB2 is a major candidate gene in asthma [13, 14] . Several polymorphisms of the ADRB2 gene have recently been recognized, including the C79G polymorphism, rs1042714, also known as Gln27Glu.
Previously published controlled clinical have investigated the role of the ADRB2 gene and the gene polymorphisms in the susceptibility to asthma in pediatric patients [10, [15] [16] [17] . However, these studies have reported inconsistent findings, because of the small number of study participants, the presence of clinical heterogeneity, or due to a combination of both factors. Therefore, this study aimed to investigate the association between the C79G polymorphism of the ADRB2 gene and its association with pediatric asthma using a meta-analysis of the published data.
Material and Methods

Study selection
Two investigators searched the literature using the PubMed, EMBASE, China National Knowledge Infrastructure (CNKI), and WanFang databases to identify controlled studies that had investigated the relationship between the expression of C79G polymorphism of the ADRB2 gene and asthma in children. The electronic literature search was conducted up to May 6 2018 and was limited to publications in the English and Chinese language. Some of the search terms used included asthma or asthmatic and polymorphism or mutation or variant and b2-AR or beta2-AR or b2-adrenergic receptor or ADRB2.
Inclusion and exclusion criteria
The published studies were selected using the following criteria: studies with a controlled design that included an asthmatic and a normal population; studies that evaluated the relationship between the C79G polymorphism of the ADRB2 gene and the risk of pediatric asthma in patients aged <18 years; studies with sufficient data to allow calculation of the odds ratio (OR) and the 95% confidence interval (CI). The following published studies were excluded: case reports; studies without available genotype frequency data; abstracts, comments, review articles, and methodological publications. The largest or most recent publication was chosen where studies had duplicated data.
Data extraction
Data were obtained from all included publications by two authors, and the information retrieved included first author, year of publication, country, ethnicity, distribution of the genotype of cases and controls, and the Hardy-Weinberg equilibrium in the controls. Any disagreement between the two investigators 
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Statistical analysis
Data analysis used the Hardy-Weinberg equilibrium. The controls for each of the studies were evaluated by Pearson's chisquared (c 2 ) test and a P-value <0.001 was regarded as a statistically significant to departure from the Hardy-Weinberg equilibrium. The odds ratio (OR) with the 95% confidence interval (CI) was used to evaluate the strength of the relationship between the C79G polymorphism of the ADRB2 gene and the risk of pediatric asthma, which was also assessed using the allelic model (G vs. C), the recessive model (GG vs. CC+CG), the dominant model (GG+CG vs. CC), and the co-dominant model (GG vs. CC and CG vs. CC), respectively. Stratification analysis was performed using ethnicity and the severity of the disease. Heterogeneity between studies was further analyzed using the c 2 -based Q test and I 2 statistic. The fixed-effects model was used when the Q-test resulted in a P-value >0.1 or the I 2 resulted in a value <50% [18] . Otherwise, the random-effects model was used [19] . Sensitivity analysis was performed by the omission of a single study at each time point to evaluate the robustness of the results. Possible bias in the publication of data were analyzed using Begg's funnel plots and Egger's test [20, 21] . Statistical analysis was performed using STATA version 15.0 (Stata Corp, College Station, TX, USA). A P-value <0.05 was considered to be statistically significant. 
Results
Characteristics of the published studies
The procedure for selection of the published studies is shown in Figure 1 . Initially, there were 386 potentially relevant publications identified during the literature search. Following primary screening using the study exclusion criteria, a total of 167 publications were eliminated, which resulted in a total of 18 controlled studies that included 2,982 pediatric patients with asthma and 2,651 controls [10, [15] [16] [17] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . The main findings of each study are summarized in Table 1 .
Association between the C79G polymorphism of the ADRB2 gene and the risk of pediatric asthma
From the 18 published studies identified (2,982 pediatric patients with asthma and 2,651 controls), the presence of the C79G polymorphism of the ADRB2 gene was significantly associated with the a reduced risk of asthma in pediatric patients using the co-dominant model (GG vs. CC: OR, 0.69; 95% CI, 0.55-0.88; P=0.002; I 2 =0) ( Figure 2 ) and the recessive model (GG vs. CC+CG: OR, 0.65; 95% CI, 0.53-0.81; P=0.000; I 2 =0) (Figure 3 ). There was no significant relationship with the other gene model. For stratification analysis according to the ethnicity, a significant relationship was found for a reduced (Figure 6 ). Stratified analysis by severity of disease showed no significant association between the presence of the C79G polymorphism of the ADRB2 gene and vulnerability to mild to moderate asthma or severe asthma when a comparison was made with the genetic model. The main results of this analysis are shown in Table 2 .
Sensitivity analysis and publication bias
Sensitivity analysis was performed to determine whether the results of the meta-analysis were significantly affected by the availability of any particular study. The findings showed that the pooled ORs were not substantially affected, which supported the strength of the results and the stability of the meta-analysis ( Figure 7 ). Begg's funnel plot and Egger's test were used to assess the potential publication bias ( Table 2 ). The symmetrical shape of the funnel plot was indicative of the lack of publication bias in the meta-analysis (Figure 8 ). Table 2 . Meta-analysis of the association between the C79G polymorphism of the ADRB2 gene and susceptibility to pediatric asthma.
OR -odds ratio; CI -confidence interval; F -fixed-effects model; R -random-effects model; NA -not available.
Discussion
Worldwide, asthma is a chronic respiratory disease that affects about 300 million people, including more than 10 million children [36, 37] . Asthma now imposes an increasing burden on health systems throughout the world [1, 38] . A first-line treatment approach for acute asthma is the use of inhaled b2-adrenergic receptor (b2-AR) agonists, due to their good bronchodilator effects, extensive therapeutic range, and few side effects [39] . However, there is significant variation in the degree of individual response to short-acting b2-agonist treatment, which is attributable to gene polymorphism [40, 41] , particularly in the ADRB2 gene that encodes for b2-AR [10, 16, 17, 42] .
The etiology of pediatric asthma remains poorly understood.
Although an increasing number of controlled clinical studies have investigated the relationship between variants of the ADRB2 gene with the risk of asthma in children, the impact of the ADRB2 gene on asthma in children remains unclear. In 2002, the finding s from a study in Taiwanese showed that there was no significant association between the presence of the C79G polymorphism of the ADRB2 gene and the risk of asthma in children [43] . This result was inconsistent with the findings of the present study. Also, a study conducted in Egypt on children with asthma showed that the presence of the C79G polymorphism was associated with increased airway hyper-responsiveness to endogenous catecholamine, which result in augmented airway sensitivity to proinflammatory stimuli resulting in long-term airway inflammation [30] . A meta-analysis to evaluate the relationship between ADRB2 gene polymorphisms and the risk of asthma in China showed that the C79G polymorphism was a contributing factor associated with increased vulnerability to asthma in adults, but no significant association was found in children [44] .
The present meta-analysis was the first to comprehensively assess the potential relationship between the presence of the C79G polymorphism of the ADRB2 gene and the risk of asthma in children. The findings contradict some of the findings from previously published studies. From this meta-analysis of 18 eligible published studies that included 2,982 pediatric patients with asthma patients and 2,651 controls, the findings were that the presence of the C79G polymorphism of the ADRB2 gene significantly reduced the risk of asthma in children. Stratified analysis according to the ethnicity showed that C79G polymorphism in the ADRB2 gene could be a protective factor for pediatric asthma, particularly in Asian populations. However, stratified analysis by disease severity showed no significant relationship between the presence of the C79G polymorphism of the ADRB2 gene and both the mild to moderate asthma and severe asthma in children. 
Conclusions
The findings from a meta-analysis of published studies on pediatric asthma showed that the C79G polymorphism of the ADRB2 gene might have a protective role, particularly in Asian populations. This study has highlighted the need for more controlled clinical studies that are well designed, large-scale, that include several ethnic groups, and that investigate environmental as well as genetic factors in the role of the C79G polymorphism of the ADRB2 gene, as well as other gene polymorphisms.
